Inactivation of Candida albicans, Staphylococcus aureus and multidrug-resistant Escherichia coli with dielectric barrier discharged cold atmospheric plasma: a comparative study with antimicrobial drugs
Journal of Medical Microbiology · 29.01.2025 · 74 (1)
DOI: 10.1099/jmm.0.001965 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Medical Microbiology, erschienen am 29.01.2025. Verfasst von Punam Talukdar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Study in Science and Technology (IASST), Guwahati 781035, Assam, India. Hauptthemen laut MEDLINE: Plasma Gases, Candida albicans, Staphylococcus aureus, Escherichia coli. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Introduction
Cold atmospheric plasma (CAP) has emerged as a promising technology for neutralizing microbes, including multidrug-resistant strains. This study investigates CAP’s potential as an alternative to traditional antimicrobial drugs for microbial inactivation. Hypothesis/Gap Statement. In the era of increasing antimicrobial resistance, there is a persistent need for alternative antimicrobial strategies. CAP exerts its effects by generating reactive oxygen and nitrogen species (RONS), but its comparative efficacy against antimicrobial drugs requires further exploration.
Aim
To evaluate the antimicrobial efficacy of CAP in inactivating multidrug-resistant Escherichia coli (ATCC BAA-2469), Staphylococcus aureus (MTCC 96) and Candida albicans (MTCC 227) and to compare its effectiveness with standard antimicrobial drugs. Methodology. CAP, produced by an indigenously developed dielectric barrier discharge (DBD) setup comprising a quartz-glass-covered high-voltage electrode and a grounded stainless steel mesh electrode, was used to treat three pathogenic samples with varying treatment times (0–60 s). The zone of inhibition (ZoI; zone where microbes cannot grow) induced by CAP was compared with the ZoI of selected antimicrobial drugs (5–300 mcg). Scanning electron microscopy (SEM) analysed morphological changes, while optical emission spectroscopy (OES) detected RONS generated during treatment. Growth curve analysis assessed CAP’s impact on microbial growth, and statistical analysis compared CAP-induced ZoI with drug-induced ZoI.
Results
CAP treatment produced substantial ZoI against E. coli , S. aureus and C. albicans, with the largest ZoI (1194±35.35 mm²) in C. albicans after 60 s. DBD–CAP showed equivalent or superior efficacy compared with selected antimicrobial drugs based on ZoI comparisons. SEM revealed extensive cellular damage in all three pathogens, with visible morphological disruption within 60 s. Growth curve analysis showed a significant delay in microbial proliferation with increasing CAP exposure, effectively inhibiting growth over 24 h. OES confirmed the presence of RONS-related molecular bands [N 2 (C–B), N 2 + (B–X) and OH(A–X)] and atomic O lines in the CAP.
Conclusion
CAP treatment exhibits equivalent or superior antimicrobial activity compared to selected antimicrobial drugs. CAP treatment exerts effects by inactivating pathogens, disintegrating cellular morphology and delaying microbial growth. These findings highlight CAP as a promising alternative to prolonged treatments, addressing antimicrobial resistance and advancing clinical strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Advanced Study in Science and Technology (IASST), Guwahati 781035, Assam, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Talukdar, P., Gohain, R. B., Bharadwaj, P., Thakur, D., & Biswas, S. (2025). Inactivation of Candida albicans, Staphylococcus aureus and multidrug-resistant Escherichia coli with dielectric barrier discharged cold atmospheric plasma: a comparative study with antimicrobial drugs. Journal of Medical Microbiology, 74(1). https://doi.org/10.1099/jmm.0.001965
Vancouver
Talukdar P, Gohain RB, Bharadwaj P, Thakur D, Biswas S. Inactivation of Candida albicans, Staphylococcus aureus and multidrug-resistant Escherichia coli with dielectric barrier discharged cold atmospheric plasma: a comparative study with antimicrobial drugs. Journal of Medical Microbiology. 2025;74(1). doi:10.1099/jmm.0.001965
BibTeX
@article{Talukdar2025,
author = {Talukdar, Punam and Gohain, Reetesh Borpatra and Bharadwaj, Pranami and Thakur, Debajit and Biswas, Subir},
title = {Inactivation of Candida albicans, Staphylococcus aureus and multidrug-resistant Escherichia coli with dielectric barrier discharged cold atmospheric plasma: a comparative study with antimicrobial drugs},
journal = {Journal of Medical Microbiology},
year = {2025},
volume = {74},
number = {1},
doi = {10.1099/jmm.0.001965}
}
EUVIMED